Madinet coated tablets 0.03 mg/2 mg. №21


Manufacturer: Germany



Hormonal contraception. The appointment of a drug Magnet should assess a woman’s individual risk factors, particularly those that relate to the risk of venous thromboembolism (VTE), and to compare the risk of VTE while taking the drug risk with other combined hormonal contraceptives (SCC) (see sections “Contraindications” and “precautions”).